Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lyudmila Tsurkan

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
British Journal of Pharmacology|July 17, 2016
Tumour-selective targeting of drug metabolizing enzymes to treat metastatic cancerMonika Wierdl, Lyudmila Tsurkan, M Jason Hatfield, et al.
Angewandte Chemie (International Ed. in English)|August 5, 2008
Directed assembly of sub-nanometer thin organic materials with programmed-size nanoporesDelia C Danila, L Todd Banner, Evguenia J Karimova, et al.
Molecular Cancer Therapeutics|September 21, 2006
Intracellular inhibition of carboxylesterases by benzil: modulation of CPT-11 cytotoxicityJanice L Hyatt, Lyudmila Tsurkan, Monika Wierdl, et al.
Journal of Medicinal Chemistry|June 19, 2009
Improved, selective, human intestinal carboxylesterase inhibitors designed to modulate 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (Irinotecan; CPT-11) toxicityLatorya D Hicks, Janice L Hyatt, Shana Stoddard, et al.
Cancer Chemotherapy and Pharmacology|June 2, 2018
Targeting ALK in pediatric RMS does not induce antitumor activity in vivoMonika Wierdl, Lyudmila Tsurkan, Liying Chi, et al.
Bioorganic & Medicinal Chemistry|July 8, 2011
Requirements for mammalian carboxylesterase inhibition by substituted ethane-1,2-dionesElizabeth I Parkinson, M Jason Hatfield, Lyudmila Tsurkan, et al.
Biochemical Pharmacology|September 14, 2010
Organ-specific carboxylesterase profiling identifies the small intestine and kidney as major contributors of activation of the anticancer prodrug CPT-11M Jason Hatfield, Lyudmila Tsurkan, Michael Garrett, et al.
Chemico-Biological Interactions|February 20, 2016
Carboxylesterases: General detoxifying enzymesM Jason Hatfield, Robyn A Umans, Janice L Hyatt, et al.
Journal of Medicinal Chemistry|March 24, 2007
Selective inhibition of carboxylesterases by isatins, indole-2,3-dionesJanice L Hyatt, Teri Moak, M Jason Hatfield, et al.
Bioorganic & Medicinal Chemistry|April 3, 2007
Analysis of the inhibition of mammalian carboxylesterases by novel fluorobenzoins and fluorobenzilsLatorya D Hicks, Janice L Hyatt, Teri Moak, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
British Journal of Pharmacology|July 17, 2016
Tumour-selective targeting of drug metabolizing enzymes to treat metastatic cancerMonika Wierdl, Lyudmila Tsurkan, M Jason Hatfield, et al.
Angewandte Chemie (International Ed. in English)|August 5, 2008
Directed assembly of sub-nanometer thin organic materials with programmed-size nanoporesDelia C Danila, L Todd Banner, Evguenia J Karimova, et al.
Molecular Cancer Therapeutics|September 21, 2006
Intracellular inhibition of carboxylesterases by benzil: modulation of CPT-11 cytotoxicityJanice L Hyatt, Lyudmila Tsurkan, Monika Wierdl, et al.
Journal of Medicinal Chemistry|June 19, 2009
Improved, selective, human intestinal carboxylesterase inhibitors designed to modulate 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (Irinotecan; CPT-11) toxicityLatorya D Hicks, Janice L Hyatt, Shana Stoddard, et al.
Cancer Chemotherapy and Pharmacology|June 2, 2018
Targeting ALK in pediatric RMS does not induce antitumor activity in vivoMonika Wierdl, Lyudmila Tsurkan, Liying Chi, et al.
Bioorganic & Medicinal Chemistry|July 8, 2011
Requirements for mammalian carboxylesterase inhibition by substituted ethane-1,2-dionesElizabeth I Parkinson, M Jason Hatfield, Lyudmila Tsurkan, et al.
Biochemical Pharmacology|September 14, 2010
Organ-specific carboxylesterase profiling identifies the small intestine and kidney as major contributors of activation of the anticancer prodrug CPT-11M Jason Hatfield, Lyudmila Tsurkan, Michael Garrett, et al.
Chemico-Biological Interactions|February 20, 2016
Carboxylesterases: General detoxifying enzymesM Jason Hatfield, Robyn A Umans, Janice L Hyatt, et al.
Journal of Medicinal Chemistry|March 24, 2007
Selective inhibition of carboxylesterases by isatins, indole-2,3-dionesJanice L Hyatt, Teri Moak, M Jason Hatfield, et al.
Bioorganic & Medicinal Chemistry|April 3, 2007
Analysis of the inhibition of mammalian carboxylesterases by novel fluorobenzoins and fluorobenzilsLatorya D Hicks, Janice L Hyatt, Teri Moak, et al.
Pageof 3